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Abstract
This study investigated that the antioxidative effect of freeze-dried cranberry powder against protein and lipid oxidation and ameliorative effect
of serum lipid profile in rat fed atherogenic diet. Six weeks old male Sprague-Dawley rats were divided into the following four groups: normal 
diet group with 5% corn oil (control), atherogenic diet group with 5% corn oil, 10% lard, 1% cholesterol, and 0.5% sodium cholate (HFC), atherogenic
plus 2% cranberry powder diet group (HFC + C2), and atherogenic plus 5% cranberry powder diet group (HFC + C5), and respective diet and water 
were fed daily for 6 weeks. After the experimental period, the serum lipid profile, such as total cholesterol, HDL-cholesterol, LDL-cholesterol,
and triglyceride, ferric reducing ability of plasma (FRAP), plasma phenolics content, superoxide dismutase (SOD) activity, serum protein carbonyl
and thiobarbituric acid reactive substances (TBARS) levels were examined. Total phenolic compound and total flavonoid levels in freeze-dried cranberry
powder were 9.94 mg/g and 8.12 mg/g, respectively. Serum total cholesterol and LDL-cholesterol levels were not significantly different for cranberry
powder treatment, but serum HDL-cholesterol level was significantly increased in HFC + C5 group compared with HFC group. Plasma FRAP value
tended to be increased by cranberry powder treatment though there was no significant difference. Plasma total phenol concentrations and SOD activities
were not significantly different among all groups. Serum protein carbonyl and TBARS levels were significantly decreased in HFC + C5 group compared
with HFC group. Overall results suggested that freeze-dried cranberry powder might have the serum lipid improving effect, as well as antioxidative
effect demonstrated by its protective effect against protein and lipid oxidation.
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Introduction3)
In recent years, there has been increasing interest in health 
and disease prevention in relation to oxidative stress. Enhanced 
oxidative stress was shown to cause general damage on cells 
by promoting the oxidation of protein and DNA and lipid 
peroxidation (Cadenas & Davies, 2000). Several studies have 
found that biomarkers of oxidative stress were improved by 
various plant food materials such as tea (Sriram et al., 2008), 
cocoa (Ramiro-Puig et al., 2007), red wine (Das et al., 2007), 
and grape juice (Dani et al., 2008), which are known to be high 
in phenolic compounds. In addition, polyphenolic constituents 
of wines and grapes juices have been reported to act as free 
radical scavengers and antimicrobial agents (Sanchez-Moreno et 
al., 1999; Shahidi & Wanasundara, 1992).
Cranberry has been shown to prevent urinary tract infections, 
inhibit peptic ulcer-associated bacterium, Helicobacter pylori, 
and induce apoptosis of carcinoma cell (Gotteland et al., 2008; 
Kontiokari  et al., 2001; Krestry et al., 2008). In addition, 
cranberry was known to have antioxidant properties as shown 
in plasma antioxidant status, protection of RBC against hemolysis 
and a cellular antioxidant activity (Villarreal et al., 2007; Wolfe 
& Liu, 2007). 
Cranberry is rich in phenolic phytochemicals such as phenolic 
acids, flavonoids and ellagic acid. These phytochemicals act as 
antioxidants, and showed health benefits including reduction of 
oxidative damage that can cause cancer, heart disease, and other 
degenerative diseases (Çelik et al., 2008; Vattem et al., 2005). 
Chu and Liu (2005) reported that phytochemicals in cranberries 
could inhibit LDL oxidation and induce expression of LDL 
receptors. Mckay and Blumberg (2007) also reported that 
cranberry reduced the risk of cardiovascular disease (CVD) by 
inhibition of LDL oxidation and platelet aggregation, and 
reducing blood pressure via other anti-thrombotic and anti- 
inflammatory mechanisms. 
Typical forms of cranberry found in markets are dried and 
ground whole fruits or dried juice. Recently, freeze-dried 
cranberry powder and 100% cranberry juice are available and 
introduced their health benefit on prevention of urinary tract 
infections (UTIs). Piljac-Žegarac et al. (2008) reported that total 
§ Corresponding  Author:  Ho-Kyung  Kwak,  Tel.  82-2-3668-4649,  Fax.  82-2-3668-4188,  Email.  hkkwak@knou.ac.krMi Joung Kim et al. 159
Table 1. Composition of control and experimental diet (%)
Grou
Ingredient Control HFC HFC + C2 HFC + C5
Casein 20 20 20 20
DL-methionine 0.3 0.3 0.3 0.3
Corn starch 29.0 17.5 15.5 12.5
S u c r o s e 4 04 04 04 0
Cellulose 1.0 1.0 1.0 1.0
C o r n  o i l 5555
Lard - 10 10 10
AIN-mineral Mix
1) 3.5 3.5 3.5 3.5
AIN-vitamin Mix
2) 1.0 1.0 1.0 1.0
Choline chloride 0.2 0.2 0.2 0.2
Cranberry powder - - 2.0 5.0
Cholesterol - 1.0 1.0 1.0
Sodium cholate - 0.5 0.5 0.5
Control:  normal  diet  control  group,
HFC:  atherogenic  diet  control  group,
HFC + C2:  atherogenic  plus  2%  cranberry  power  diet  group,
HFC + C5:  atherogenic  plus  5%  cranberry  power  diet  group.
1) Composition  of  AIN-76  salt  mixture
2) Composition  of  AIN-76  vitamin  mixture
phenolics level in cranberry juice was 1546.9 mg/L and Chen 
et al. (2001) reported that cranberry juice had 400 mg/L of total 
phenolics. Vinson et al. (2008) reported that the amount of total 
phenols in cranberry foods was higher in dried or frozen products 
than in 100% cranberry juices.
However, most studies used cranberry extract or juice for 
testing its in vivo antioxidant function. In addition, it is limited 
that investigators studied freeze-dried cranberry powder and its 
antioxidant and cardiovascular protective effects. Therefore, we 
employed freeze-dried cranberry powder and investigated its 
possible health benefits using animal model. In the present paper, 
we report the antioxidative effect against protein and lipid 
oxidation and serum lipid profile ameliorative effect of freeze- 
dried cranberry powder in rats fed atherogenic diet.
Materials and Methods
Animals and diet
Six-week-old, 30 male Sprague-Dawley rats, weighing 160-190 g, 
were obtained from Animals Co. (Daehan, Korea) and maintained 
under a specific condition with a temperature-controlled (23 ±
2℃) and humidity-controlled (50 ± 10%). After a 7-day acclima-
tion period, animals were divided into the following four groups 
on the basis of comparable mean body weight: 5% corn oil normal 
diet group (Control, n=7), atherogenic diet group containing 5% 
corn oil, 10% lard, 1% cholesterol, and 0.5% sodium cholate 
(HFC, n=7), atherogenic plus 2% cranberry powder diet group 
(HFC + C2, n=8), and atherogenic plus 5% cranberry powder diet 
(HFC + C5, n=8). Freeze-dried cranberry powder was purchased 
from Mastertaste Co. (USA) and all diets were the modified AIN-76 
(American Institute of Nutrition, 1977) (Table 1). The experimental 
diets and water were fed ad libitum for 6 weeks from the beginning 
of the experiment. Food intake was recorded daily and the body 
weight was measured weekly. The end of the experimental period, 
the animals anesthetized with ethyl ether after 12 hours fasting 
and blood from the saphenons vein and the liver samples were 
collected. Blood samples were collected in vacuum tube 
(Becton-Dickinson, Meylan, France) without anticoagulant for 
lipid profiles and biochemical analysis, and with heparin for 
erythrocyte lysate preparation. All blood samples were immediately 
centrifuged (3,000 rpm, 20 min, 4℃) for the separation of serum, 
plasma, and erythrocyte. Erythrocyte samples were lysed in 4 
times with ice cold HPLC-grade water and centrifuged (10,000 
g, 15 min, 4℃), and the supernatant (erythrocyte lysate) was 
collected for erythrocyte superoxide dismutase (SOD) activity 
analysis. All samples were stored at -80℃ and thawed only once, 
just before analysis.
Lipid profiles
Serum total cholesterol, HDL-cholesterol, and triglyceride were 
detected by enzymatic assay using automatic biochemical 
analyzing system (Vitalab Selectra E, Vital Scientific N.V., the 
Netherlands). LDL-cholesterol level was calculated by a formula 
of Friendewald et al.  (1972).
Ferric reducing ability of plasma (FRAP)
Plasma antioxidant status was evaluated using ferric reducing 
ability of plasma (FRAP) assay (Benzie & Strain, 1996). At low 
pH, the ferric-tripyridyltriazine (Fe(III)-TPTZ) complex is 
reduced to ferrous tripyridyltriazine (Fe(II)-TPTZ), which is color 
marker, depends on the ability of sample. Two hundred seventy 
μl of pre-warmed (at 37℃) freshly prepared FRAP reagent (25 
ml of 300 mM sodium acetate buffer pH 3.6, 2.5 ml of 10 mM 
2,4,6-tri(2-pyridil)-s-triazine (TPTZ) in 40 mM HCl, 2.5 ml of 
20 mM ferric chloride solution) were mixed with 30 μl of plasma 
diluents. After 15 min incubation at 37℃, absorbance was read at 
550 nm. FRAP values are measured by detection of the absorbance 
change of test sample as the reducing power of antioxidants 
present in the plasma comparing with that of trolox standard.
Total phenolics and total flavonoid assay
The total soluble phenolic compounds were determined in 
cranberry powder and plasma with the Folin-Ciocalteu reagent 
according to the method of Singleton et al. (1965) using gallic 
acid as standard. Mixture of 50 μl sample (plasma or 100 mg 
freeze-dried cranberry powder in 1 ml of distilled water) and 
865 μl distilled water was incubated with 75 μl Folin-Ciocalteu 
reagent at room temperature for 5 min. Two hundred twenty five 
μl of 20% Na2CO3  and 285 μl of distilled water were added 
to the reaction mixture which was incubated at room temperature 
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Table 2. Total phenolic compound and total flavonoid levels in cranberry powder
Content
Total phenolic compound 
(mg gallic acid equivalents/g) 9.94 ± 0.13
Total flavonoid 
(mg catechin equivalents/g) 8.12 ± 0.25
Values  are  mean ± SD.
Fig. 1. Change of body weights in rat.  Values  are  mean. 
phenolic content is expressed as gallic acid equivalent (GAE) 
in mM of plasma and milligrams per gram of dried sample. 
The total flavonoid level in freeze-dried cranberry powder was 
measured by spectropotometric method using catechin as 
standard (Jia et al., 1999). Five hundred μl of diluted sample 
with distilled water and 75 μl of 5% NaNO2 solution were mixed 
and incubated at room temperature for 5 min. This mixture was 
added 150 μl of 10% AlCl3 and allowed to stand for a further 
5 min before 0.5 ml of 1 M NaOH was added. The solution 
was measured the absorbance at 510 nm. The results were 
expressed as catechin equivalent in milligrams per gram of 
freeze-dried cranberry powder.
Plasam and erythrocyte lysate superoxide dismutase (SOD) activity
Superoxide dismutase (SOD) activities of plasma and 
erythrocyte lysate were measured by microplate assay method 
based on the detection of superoxide radicals generated by 
xanthine oxidase and hypoxanthine using the commercial kit 
(Cayman chemical superoxide dismutase assay kit, Cayman 
Chemical Co., USA).
Serum protein carbonyl and thiobarbituric acid reactive 
substances levels 
Serum protein carbonyl levels were determined by enzyme linked 
immunosorbent assay (ELISA) based on the detection of protein 
hydrazones form from the reaction of dinitrophenylhydrazine 
(DNP) with protein carbonyl using the Biocell PC test kit ( BioCell 
Corp., Ltd., New Zealand). 
Serum thiobarbituric acid reactive substances (TBARS), which 
is the important marker of lipid peroxidation, was determined 
by spectrophotometric method using the OXItek TBARS kit 
(ZeptoMetrix Co., USA).
Statistical analysis
Statistical programs available in SAS program (version 9.1, 
SAS Inc, Cary, NC, USA) were utilized for data analysis. The 
significance of difference among the groups was assessed using 
one-way analysis of variance and Duncan’s multiple range tests. 
Values are presented as the mean ± standard deviation, and a 
significance test on all results was conducted at level of p<0.05 
unless otherwise stated. 
Results
Total phenolics and total flavonoids in cranberry powder
Total phenolic compound and total flavonoid levels in 
freeze-dried cranberry powder were 9.94 mg/g and 8.12 mg/g 
respectively (Table 2).
Weights and food intake
Weight gains, mean of food intake, and food efficiency ratio 
(FER) are shown in Table 3 and body weight change are shown 
in Fig. 1. Body weights were gradually increased in all groups, 
and the weight gains and mean of food intake were decreased 
in HFC + C5 group (146.2 g, 13.5 g/day) compared with control 
(182.5 g, 15.5 g/day) or HFC groups (194.5 g, 15.4 g/day), but 
FER was not significant difference between HFC + C5 (0.25 
g/100 g body weight) and control (0.26 g/100 g body weight) 
or HFC group (0.31 g/100 g body weight). 
The final body weight also was decreased in HFC + C5 group 
compared with control or HFC groups (Table 3). The liver weight 
and relative liver weight were significantly increased in all 
atherogenic diet groups than in normal diet group, but the liver 
weight was decreased in HFC + C5 group (17.8 g) compared with 
the HFC group (23.0 g) (Table 3).
Lipid profiles
The results about the effect of cranberry powder on serum lipid 
profiles are shown in Table 4. Average of serum triglyceride 
level in control group was significantly higher than that in all 
atherogenic diet groups. Serum total cholesterol and LDL- 
cholesterol levels were significantly increased by atherogenic 
diets, but there was no significant difference for cranberry powder 
treatment. Serum HDL-cholesterol level and HDL/LDL ratio 
were significantly decreased in all atherogenic diet groups 
compared with normal diet group. However serum HDL- Mi Joung Kim et al. 161
Table 4. Effects of cranberry powder on serum lipid profiles in diet-induced hyperlipidemia rat
1)
Group (n) Triglyceride (mg/dl) Total cholesterol (mg/dl) HDL-cholesterol (mg/dl) LDL-cholesterol (mg/dl) HDL/LDL ratio
Control (7) 112.5 ± 49.2
a 200.5 ±  20.8
b 62.9 ±  3.3
a 113.3 ±  14.1
b 0.535 ± 0.040
a 
HFC (7)   51.9 ± 15.6
b 456.1 ±  82.5
a 38.7 ±  8.3
c 407.0 ±  81.8
a 0.098 ± 0.023
b
HFC + C2 (8)  71.3 ± 35.2
b 468.8 ± 170.3
a 36.6 ±  6.1
c 417.9 ± 171.2
a 0.098 ± 0.036
b
HFC + C5 (7)  70.0 ± 29.2
b 504.1 ±  99.1
a 49.7 ± 12.6
b 436.3 ±  95.5
a 0.106 ± 0.046
b
n:  number  of  animals,
Control:  normal  diet  control  group,
HFC:  atherogenic  diet  control  group,
HFC + C2:  atherogenic  plus  2%  cranberry  power  diet  group,
HFC + C5:  atherogenic  plus  5%  cranberry  power  diet  group.
1) V a l u e s  a r e  m e a n  e x c l u d i n g  o n e  o f  t h e  d a t a  o v e r  2 S D±S D , 
Means  with  the  different  superscripts  are  significantly  different  at  p<0.05  by  Duncan's  multiple  range  test. 
Table 3. Effects of cranberry powder on food intake, food intake efficiency ratio (FER), weight gains, final body weight, liver weight, and relative liver weight in
diet-induced hyperlipidemia rat
Group (n) Food intake
(g/day)
FER
2)
(g/100 g body weight)
Weight gains
3)
(g)
Final body weight
(g)
Liver weight
(g)
Relative liver weight
(g/100 g body weight)
Control (7) 15.5 ± 0.6
a 0.26 ± 0.03
ab 182.5 ± 16.3
a 362.5 ± 19.6
a 12.4 ± 1.6
c 3.42 ± 0.36
b
HFC (7) 15.4 ± 0.9
a 0.31 ± 0.04
ab 194.5 ± 34.4
a 374.5 ± 34.5
a 23.0 ± 3.6
a 6.13 ± 0.42
a
HFC + C2 (8) 14.7 ± 0.5
b 0.31 ± 0.06
a 192.9 ± 38.7
a 372.9 ± 40.0
a 21.3 ± 3.9
a 5.66 ± 0.53
a
HFC + C5 (8) 13.5 ± 0.5
c 0.25 ± 0.06
b 146.2 ± 28.5
b 326.3 ± 24.8
b 17.8 ± 2.5
b 5.48 ± 0.86
a
n:  number  of  animals,
Control:  normal  diet  control  group,
HFC:  atherogenic  diet  control  group,
HFC + C2:  atherogenic  plus  2%  cranberry  power  diet  group,
HFC + C5:  atherogenic  plus  5%  cranberry  power  diet  group.
1) Values  are  mean ± SD, 
Means  with  the  different  superscripts  are  significantly  different  at  p<0.05  by  Duncan's  multiple  range  test. 
2) FER:  food  intake  efficiency  ratio
3) T o t a l  b o d y  w e i g h t  g a i n s  f o r  6  w e e k s
Table 5. Effects of cranberry powder on plasma FRAP and total phenolic levels
in diet-induced hyperlipidemia rat
1)
Group (n) FRAP
2)
(μM)
Total phenolic level
(mM gallic acid equivalents)
Control (7) 172.9 ± 54.2
NS 6.08 ± 0.20
NS
HFC (6) 180.6 ± 59.0 6.27 ± 0.17
HFC + C2 (8) 228.8 ± 82.5 6.16 ± 0.39
HFC + C5 (8) 217.4 ± 64.2 6.06 ± 0.30
n:  number  of  animals,
Control:  normal  diet  control  group,
HFC:  atherogenic  diet  control  group,
HFC + C2:  atherogenic  plus  2%  cranberry  power  diet  group,
HFC + C5:  atherogenic  plus  5%  cranberry  power  diet  group.
1) Values  are  mean ± SD, 
Means  with  the  different  superscripts  are  significantly  different  at  p<0.05  by 
Duncan's  multiple  range  test. 
2) FRAP:  the  ferric  reducing  ability  of  plasma
Table 6. Effects of cranberry powder on plasma and erythrocyte lysate SOD
activity in diet-induced hyperlipidemia rat
1)
Group (n) SOD
2)  activity in plasma
(U/ml)
SOD
 activity in erythrocyte
 (U/ml)
Control (7) 23.1 ±   9.8
NS 653.6 ± 338.1
NS
HFC (7) 27.0 ± 12.3 657.8 ± 218.1
HFC + C2 (8) 29.0 ± 10.9 578.7 ± 273.4
HFC + C5 (8) 26.2 ±   8.1 422.7 ± 205.4
n:  number  of  animals,
Control:  normal  diet  control  group,
HFC:  atherogenic  diet  control  group,
HFC + C2:  atherogenic  plus  2%  cranberry  power  diet  group,
HFC + C5:  atherogenic  plus  5%  cranberry  power  diet  group.
1) Values  are  mean ± SD, 
Means  with  the  different  superscripts  are  significantly  different  at  p<0.05  by 
Duncan's  multiple  range  test. 
2) SOD:  superoxide  dismutase
cholesterol was significantly increased in HFC + C5 group (49.7 
mg/dl) compared with HFC group (38.7 mg/dl) (Table 4). 
Plasma FRAP, total phenolics levels and SOD activity
Plasma FRAP and total phenolics levels were detected to 
examine the effects of cranberry powder on antioxidant status. 
Average of plasma FRAP value shown tended to be increased 
by cranberry powder treatment, but there was no significant 
difference (control; 172.9 μM, HFC; 180.6 μM, HFC + C2; 228.8 
μM, HFC + C5; 217.4 μM). Plasma total phenolic content was 
not significantly different for atherogenic diet or cranberry 
powder treatment (Table 5). 
Plasma SOD activity was also not significantly different by 
atherogenic diet or cranberry powder treatment, but erythrocyte 
SOD activity showed a tendency to be decreased by cranberry 
powder treatment although there was not significant (Table 6).
Serum protein carbonyls and TBARS levels
Serum protein carbonyl and TBARS levels were measured to 
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Table 7. Effects of cranberry powder on serum protein carbonyl and TBARS
levels in diet-induced hyperlipidemia rat
1)
Group (n) Protein carbonyl
(nmol/mg)
TBARS
2)
(nmol/ml)
Control (7) 0.58 ± 0.11
a 14.7 ± 3.3
ab
HFC (7) 0.51 ± 0.05
ab 15.9 ± 3.8
a
HFC + C2 (8) 0.47 ± 0.04
b 15.6 ± 6.0
a
HFC + C5 (8) 0.24 ± 0.05
c 10.7 ± 3.6
b
n:  number  of  animals,
Control:  normal  diet  control  group,
HFC:  atherogenic  diet  control  group,
HFC + C2:  atherogenic  plus  2%  cranberry  power  diet  group,
HFC + C5:  atherogenic  plus  5%  cranberry  power  diet  group.
1) Values  are  mean ± SD, 
Means  with  the  different  superscripts  are  significantly  different  at  p<0.05  by 
Duncan's  multiple  range  test. 
2) TBARS:  thiobarbituric  acid  reactive  substances
oxidative damage such as protein oxidation and lipid peroxida-
tion. Mean serum protein carbonyl level was found to be 
significantly decreased in HFC + C2 (0.47 mmol/mg) and HFC
+ C5 groups (0.24 nmol/mg) as compared to control group (0.58 
nmol/mg) and significantly decreased in HFC + C5 group as 
compared to HFC group (0.51 nmol/mg) (Table 8). Serum 
TBARS level was also significantly decreased in HFC + C5 
group (10.7 nmol/ml) compared with HFC group (15.9 nmol/ml) 
(Table 7). 
Discussion
This study examined the serum lipid profile ameliorative and 
antioxidative effects of freeze-dried cranberry powder in rats fed 
atherogenic diet. Cranberry is known to be a good source of 
antioxidants, which have health benefits such as anti-adhension 
activity, antiviral, and anticancer properties (Bomser et al., 1996; 
Howell  et al., 2005). 
In this study, we used freeze-dried cranberry powder, and its 
total phenolics and total flavonoid levels were 9.94 mg/g and 
8.12 mg/g, respectively. Sun et al. (2002) reported that cranberry 
had the highest total phenolic content, followed by apple, red 
grape, strawberry, pineapple, banana, peach, lemon, orange, pear, 
and grapefruit. Çelik et al. (2008) reported that total phenolics 
contents of cranberry fruits were different among each maturation 
stage and dark red cranberry had 4.745 mg gallic acid 
equivalents/g of total phenolics. Vinson et al. (2005) also 
reported that the average total phenols were 663 mg/100 g for 
fresh cranberries and 870 mg/100 g for dried cranberries, which 
was a similar level with our study. According to the study of 
Vinson et al. (2008), the amount of total phenols in cranberry 
foods on fresh weight basis was higher in dried or frozen products 
than in juice or sauce forms. Piljac-Žegarac et al. (2008) reported 
that total phenolics level in cranberry juice was 1546.9 mg/L. 
Chen et al. (2001) reported that cranberry juice had 400 mg/L 
of total phenolics including flavonoids, and the major forms of 
phenolics and flavonoids were benzoic acid, quercetin and 
myricetin. In a study of Bailey et al. (2007), concentrated 
cranberry extract with 30% phenolics was used to investigate 
its effects on the recurrent urinary tract infections (UTIs) in 
women, since the concentrated active phenolics might be more 
effective in preventing UTIs. However, the optimum level and 
form of administration was not suggested. In the current study, 
we used just freeze-dried powder because its total phenolics level 
was higher than fresh or juice type of cranberry and it was a 
natural food form without excess processes such as concentration 
and extraction.
Mckay and Blumberg (2007) suggested that polyphenols in 
cranberry might reduce the cardiovascular disease risk factor such 
as LDL oxidation, platelet aggregation, and high blood pressure. 
Ghazala et al. (2008) also reported that plasma LDL-cholesterol 
and LDL oxidation were reduced by cranberry extract fortification. 
However, Ruel et al. (2006) reported that total and LDL-cholesterol 
were not changed but HDL-cholesterol was increased by cranberry 
juice consumption in men. In the current study, we also observed 
similar results that serum total cholesterol and LDL-cholesterol 
levels were not significantly different in rats with and without 
cranberry powder treatment, but serum HDL-cholesterol level was 
significantly increased by 5% cranberry powder fortification. 
Deyhim et al. (2007) also reported that drinking cranberry juice 
increased plasma antioxidant capacity but did not change the 
cholesterol concentrations in liver and plasma of rat and it assumed 
that cranberry juice might increase antioxidant status without 
affecting cholesterol homeostasis. 
In case of in vitro study, cranberry was known that it has 
abundant phytochemicals and the highest cellular antioxidant 
activity among tested food materials including apple, red grape 
and green grape (Wolfe & Liu, 2007). Villarreal et al. (2007) 
also reported that plasma antioxidant status was increased and 
red blood cell was protected against hemolysis by drinking 
cranberry juice in rats. In this study, plasma total antioxidant 
capacity measure by FRAP tended to be increased by cranberry 
powder treatment, although there was no significant difference. 
In several short-term intervention studies for cranberry juice, it 
was shown that plasma antioxidant capacity was increased by 
cranberry juice consumption (Ruel et al., 2005; Zhang & Zue, 
2004).
Pedersen  et al. (2000) reported that total phenolics level in 
plasma was slightly increased four hours following 500 ml 
cranberry juice consumption for one time. However, according 
to the study of Ruel et al. (2005), dietary and possibly active 
compounds from cranberry juice were rapidly degraded in plasma 
after consumption. This metabolic degradation might explain in 
part the findings observed in a study by Duthie et al. (2006) 
and the current study. Duthie et al. (2006) showed that total 
phenols in fasting plasma were not different between cranberry 
juice consumption and placebo groups in their 2 week study. 
When rats were fed atherogenic diet fortified with cranberry 
powder, we also failed to observe the significant changes in total 
phenolics content of fasting plasma.Mi Joung Kim et al. 163
In this study, plasma and erythrocyte SOD activities were not 
significantly different by atherogenic diet or cranberry powder 
treatment. Similarly, Duthie et al. (2006) found that plasma SOD 
activities were not different between cranberry juice consumption 
and placebo groups. However, there was a conflict finding 
observed in a study by Deyhim et al. (2007), which reported 
that cranberry juice increased plasma SOD activity. For 
biomarkers of protein and lipid oxidation, mean serum protein 
carbonyl and TBARS levels were significantly decreased in 5% 
cranberry powder treated group compared with atherogenic diet 
fed group in this study. Serum protein carbonyl formation has 
been proposed to be an early marker for protein oxidation 
(Reznick & Packer, 1994) and serum TBARS is regarded as a 
marker of lipid peroxidation. In a human intervention study with 
the dried cranberry juice, serum protein oxidation level was 
significantly decreased by a 1200 mg of dried cranberry juice 
consumption (Valentova et al., 2007). Deyhim et al. (2007) 
reported that cranberry juice increased plasma antioxidant 
capacity and reduced malondialdehyde concentrations. Vattem et 
al. (2005) also reported that cranberry phenolics decreased MDA 
formation in oxidatively stressed porcine muscle and it suggested 
that exogenously treated phenolic phytochemicals could be 
reducing the oxidative stress. Including the results from the 
current study, several trials have shown beneficial effect of 
cranberry consumption on protein and lipid oxidation. These 
consensus outcomes may explain the antioxidative effect of 
cranberry powder and juice against oxidative damage. 
Overall results of the present study showed that 5% of the 
freeze-dried cranberry powder treatment increased HDL- 
cholesterol and reduced protein carbonyl and TBARS levels in 
rat fed atherogenic diet. It assumed that cranberry powder might 
have the plasma lipid improving effect and antioxidant effect 
against oxidative damage. However, since the current study was 
done in animal model, the findings from this study cannot be 
applied to the human diet directly. Therefore, further studies are 
needed to evaluate health benefits and effective dose of cranberry 
powder in humans. In addition, it is suggested that the 
mechanisms of antioxidant action and lipid improving effect of 
cranberry powder and its components should be elucidated for 
better understanding the health benefits of this plant food with 
high phenolics. 
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